Position in MRK
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$60,842,565
+$3,934,449 QoQ
Shares Held
473,483
+0.1% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.38%
of 13F equity value
Holder Rank
#278
of 3,769 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026XPONANCE LLC holds $673,665,379 across 15 Drug Manufacturers - General names. MRK ranks #4 (9.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
222,559 | $266,943,963 | |
| 2 | JNJ |
Johnson & Johnson
|
466,851 | $118,566,148 | |
| 3 | ABBV |
AbbVie Inc.
|
350,912 | $88,303,495 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
473,483 | $60,842,565 | |
| 5 | AMGN |
Amgen Inc
|
133,818 | $48,458,174 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
238,168 | $30,090,145 | |
| 7 | PFE |
Pfizer Inc
|
1,108,420 | $26,690,753 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
444,025 | $25,584,720 |
All Filings in MRK
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $60,842,565 | 473,483 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $56,908,116 | 473,091 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $43,494,589 | 413,211 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $34,507,399 | 411,145 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $34,104,581 | 430,831 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $56,234,280 | 626,496 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $60,045,730 | 603,596 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $66,448,384 | 585,139 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $73,214,577 | 591,394 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $53,070,026 | 402,198 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $44,976,855 | 412,556 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $39,548,242 | 384,150 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $43,639,113 | 378,188 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $46,469,662 | 436,786 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $47,022,385 | 423,816 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $32,937,024 | 382,455 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $31,105,562 | 341,182 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $16,739,512 | 204,016 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $15,275,118 | 199,310 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $9,846,921 | 131,100 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $12,016,242 | 154,510 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $35,407,610 | 459,302 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $37,712,237 | 461,030 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $38,005,716 | 458,176 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $37,519,217 | 485,183 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||